The principal scientific journal for the profession in New Zealand

Vol 135 No 1562: 23 September 2022

Regional vs Metropolitan. Bigger is not always better.

ARTICLE
Vol 135 No 1562: 23 September 2022

Trauma Team Activation: improved care of major trauma patients

Injury is the leading cause of death for New Zealanders under the age of 35 and is the second leading cause of hospitalisation.

ARTICLE
Vol 135 No 1562: 23 September 2022

Teleclinics for the management of diabetes in pregnancy during COVID-19—maternal satisfaction and pregnancy outcomes | OPEN ACCESS

Diabetes in pregnancy (DiP) describes both gestational (GDM; glucose intolerance first recognised in pregnancy), or pre-existing (type I or II) diabetes.

ARTICLE
Vol 135 No 1562: 23 September 2022

Seeking of help and support after experiencing sexual harm: considerations for cisgender women, cisgender men and gender-diverse people

There is a recognised gap, both within the research literature and clinical settings, regarding provision of specialised support and treatment for male and gender-diverse (including all gender identities outside the gender binary male/female) survivors of sexual harm (including any type of forced or coerced sexual contact, assault, harassment or behaviour that happens without consent).

ARTICLE
Vol 135 No 1562: 23 September 2022

Helicobacter pylori in New Zealand: current diagnostic trends and related costs

Helicobacter pylori (Hp) related chronic gastritis is a common infection with varied prevalence rates throughout the world.

ARTICLE
Vol 135 No 1562: 23 September 2022

Transfusion practice in patients undergoing cardiac surgery in New Zealand—impact of the TRICS III study (the TRICS TRIPS study)

Cardiac surgery is the largest perioperative user of donated blood products accounting for 14–20% of total blood product consumption and consuming 50% of all red blood cell (RBC) transfusions given to surgical patients.

ARTICLE
Vol 135 No 1562: 23 September 2022

Cannabis use and patterns of psychotic symptomatology in a longitudinal birth cohort

Cannabis is a drug used widely for “recreational” purposes, with over 75% of New Zealanders have reported using cannabis at least once by age 25, and with 12.5% showing use consistent with the Diagnostic and Statistical Manual of Mental Disorders (DSM) criteria for dependence.

ARTICLE
Vol 135 No 1562: 23 September 2022

Improving health services for patients with extreme obesity requiring bariatric level care at Wellington Regional Hospital: a clinical audit

Bariatric service delivery refers to the care received by those with additional needs due to extreme obesity; this includes appropriate spatial facility design, equipment uses, and collection of information needed to inform high quality services. It does not explicitly relate to specialist care for weight loss management (i.e., bariatric surgery).

ARTICLE
Vol 135 No 1561: 2 September 2022

E-cigarette use patterns, brand preference and knowledge about vaping among teenagers (13–16 years) and parents of children attending Christchurch Hospital

Currently in New Zealand, patients are asked about whether they smoke on admission to hospital, but information is lacking whether vaping is also asked. Understanding the e-cigarette use habits and knowledge of patients about vaping presenting to hospital can enable clinicians to provide relevant information to help patients make informed decisions.

ARTICLE
Vol 135 No 1561: 2 September 2022

Audit of cervical excision depth of large loop excision of the transformation zone procedures at Counties Manukau District Health Board

Cervical cancer is the fourth most common malignancy in females worldwide, affecting 5.7 per 100,000 women in New Zealand, with higher rates in Māori compared to non-Māori (8.1 vs 4.4, per 100,000 women, respectively). Despite Australia and New Zealand both having some of the lowest rates of cervical cancer in the world,[[4]] cervical cancer remains an important and preventable cause of morbidity and mortality.

ARTICLE
Vol 135 No 1561: 2 September 2022

Epidemiology of carbapenem resistant Acinetobacter baumannii in New Zealand

Acinetobacter baumannii is a gram-negative coccobacillus that has emerged as a multi-drug resistant (MDR) cause of hospital acquired infection in many locations worldwide. Infections primarily affect vulnerable patients in the intensive care setting and are associated with high crude mortality. The emergence of MDR A. baumannii has occurred in association with regional and international spread of hospital adapted clones.